Skip to main content
logo
The Cigna Group (CI)
NYSE: CI · Real-Time Price · USD
311.96
+6.55 (2.14%)
Nov 5, 2026, 11:05 AM EST - Market open

The Cigna Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Capitalization
82,43272,92670,33273,52176,94288,31289,19576,80996,84793,906103,01887,62584,67183,02275,901101,30484,66183,60876,28676,10668,076
Market Cap Growth (YoY)
19.32%-17.42%-21.15%-4.28%-20.55%-5.96%-13.42%-12.34%14.38%13.11%35.73%-13.50%0.01%-0.70%-0.51%33.11%24.36%2.78%-9.16%1.19%9.43%
Enterprise Value
107,05396,20693,224100,862102,784109,887113,162103,062121,078117,296125,774109,297107,028106,809100,704125,613113,484112,277104,622106,23496,744
Last Close Price
305.41274.16263.75270.64281.86321.63318.56266.07332.41315.97345.72283.86269.91263.57238.90308.46257.42243.53220.47210.29182.39

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
12.9011.3711.1912.3412.5217.6017.7222.3731.8725.33-16.9715.8912.4311.2115.1112.7815.2314.1214.198.12
Forward PE
9.358.938.799.019.0510.6511.079.0111.5411.3612.7710.9410.8010.9110.3313.8911.8111.5310.6510.599.45
PS Ratio
0.290.260.250.270.290.340.350.310.420.430.500.450.450.450.420.560.470.470.430.440.40
PB Ratio
1.891.701.661.761.832.182.211.862.292.262.491.891.851.821.702.261.881.821.651.611.43
P/FCF Ratio
9.04-9.188.7610.35-14.848.57--10.148.567.777.277.4113.768.849.9511.0112.6111.27
P/OCF Ratio
8.02-7.987.668.88-11.987.4114.639.998.867.426.806.446.5111.707.828.659.3910.589.44
PEG Ratio
0.890.880.770.920.740.871.070.651.021.051.180.880.900.900.771.070.960.960.860.850.69

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
EV/Sales Ratio
0.380.340.340.370.380.420.440.420.520.540.610.560.560.570.550.700.630.630.590.610.57
EV/EBITDA Ratio
8.396.556.517.778.158.849.068.279.549.3110.189.069.379.638.9410.979.879.659.209.598.98
EV/EBIT Ratio
9.718.058.069.8910.3711.2411.5710.6312.3612.2413.4912.1012.7113.1512.1414.7513.2812.9312.3913.0312.27
EV/FCF Ratio
11.75-12.1712.0213.82-18.8311.51--12.3810.679.839.369.8417.0711.8513.3615.1017.6016.02

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
0.740.740.730.750.810.760.750.780.780.770.790.670.680.720.730.710.710.740.730.730.74
Debt / EBITDA Ratio
2.502.271.752.402.442.442.492.742.482.482.702.462.432.752.963.112.742.652.823.312.83
Debt / FCF Ratio
3.50-4.033.754.58-5.073.57--3.233.022.862.873.184.293.354.044.875.685.78
Net Debt / Equity Ratio
0.570.570.540.540.650.630.530.580.620.580.560.480.470.490.530.550.540.630.620.600.63
Net Debt / EBITDA Ratio
1.931.681.611.752.152.061.711.912.051.911.881.841.892.012.102.162.112.472.522.552.79
Net Debt / FCF Ratio
2.702.703.012.713.656.503.562.655.033.022.292.171.981.952.313.362.533.424.134.684.98
Asset Turnover
1.831.831.831.751.701.711.681.601.511.431.371.321.291.231.221.211.211.171.161.121.08
Inventory Turnover
43.4444.6237.6840.7443.7143.8139.7040.2144.5344.0739.6135.4238.1338.9536.0536.4540.5543.2342.1947.4550.68
Quick Ratio
0.690.690.660.670.690.640.650.560.610.600.580.540.610.610.600.580.620.520.490.480.59
Current Ratio
0.850.850.820.850.830.790.780.840.860.840.830.770.730.730.720.730.730.830.810.830.70
Return on Equity (ROE)
16.76%16.76%16.27%15.13%15.54%13.18%13.21%8.63%7.61%9.13%8.97%11.79%12.07%14.90%15.15%14.75%14.45%11.72%11.56%11.11%17.63%
Return on Assets (ROA)
4.46%4.46%4.78%4.09%3.95%3.98%4.03%3.92%3.98%3.92%3.87%3.81%3.58%3.36%3.45%3.59%3.58%3.54%3.46%3.29%3.14%
Return on Invested Capital (ROIC)
13.39%14.43%14.55%12.69%11.88%11.55%12.09%-0.83%0.12%0.25%-0.12%11.17%10.12%9.40%9.53%9.52%9.35%9.17%9.14%8.83%7.90%
Return on Capital Employed (ROCE)
10.90%11.80%11.50%10.00%9.80%10.30%10.30%9.90%9.70%9.60%9.20%8.70%8.20%7.90%8.00%8.30%8.30%8.10%7.80%7.30%6.70%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Nov '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
7.75%8.80%8.94%8.10%7.99%5.68%5.64%4.47%3.14%3.95%3.51%5.89%6.29%8.04%8.92%6.62%7.83%6.57%7.08%7.05%12.32%
FCF Yield
11.06%12.50%10.89%11.41%9.67%4.47%6.74%11.66%5.35%8.48%9.86%11.69%12.86%13.75%13.49%7.27%11.31%10.05%9.08%7.93%8.87%
Dividend Yield
1.99%2.22%2.29%2.16%2.05%1.76%1.73%2.00%1.57%1.57%1.40%1.64%1.67%1.67%1.79%1.32%1.57%1.60%1.72%1.70%1.46%
Payout Ratio
25.80%24.64%25.21%32.09%21.52%26.17%31.14%26.97%52.77%25.32%-34.79%25.71%24.80%29.04%28.00%12.37%22.61%29.83%29.03%20.36%
Buyback Yield / Dilution
3.55%1.56%3.27%4.36%4.93%5.60%4.72%5.70%5.30%4.32%4.19%3.55%3.38%6.73%6.94%7.35%8.91%7.72%8.72%8.72%8.06%
Total Shareholder Return
5.54%3.78%5.56%6.53%6.98%7.35%6.44%7.69%6.86%5.89%5.60%5.19%5.04%8.40%8.73%8.67%10.48%9.32%10.44%10.41%9.52%
SEC Filings: 10-K · 10-Q